1. Home
  2. ONEW vs MOLN Comparison

ONEW vs MOLN Comparison

Compare ONEW & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$12.91

Market Cap

174.4M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.15

Market Cap

151.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
MOLN
Founded
2014
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
174.4M
151.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ONEW
MOLN
Price
$12.91
$4.15
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$16.75
$8.38
AVG Volume (30 Days)
183.0K
5.9K
Earning Date
01-29-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
$2.23
N/A
Revenue Next Year
$3.55
$999.99
P/E Ratio
N/A
N/A
Revenue Growth
5.63
N/A
52 Week Low
$10.14
$3.36
52 Week High
$21.00
$5.35

Technical Indicators

Market Signals
Indicator
ONEW
MOLN
Relative Strength Index (RSI) 50.29 49.36
Support Level $13.18 $3.97
Resistance Level $15.25 $4.27
Average True Range (ATR) 0.81 0.17
MACD -0.04 -0.00
Stochastic Oscillator 9.46 53.65

Price Performance

Historical Comparison
ONEW
MOLN

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: